Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy

Purpose: To compare the efficacy and safety of 6-weekly and 12-weekly intravenous methylprednisolone (IVMP) regimens in moderate-to-severe, active thyroid-associated orbitopathy (TAO) patients. Basic Procedures: Retrospective comparative study of patients who received IVMP between January 2011 and J...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Kenneth K. H., Aljufairi, Fatema Mohamed Ali Abdulla, Li, Chi Lai, Ngai, Amanda K. Y., Yeung, Carly S. K., Fong, Ryan H. Y., Yip, Wilson W. K., Young, Alvin L., Pang, Chi Pui, Chong, Kelvin K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179467/
https://www.ncbi.nlm.nih.gov/pubmed/37176682
http://dx.doi.org/10.3390/jcm12093244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179467/
https://www.ncbi.nlm.nih.gov/pubmed/37176682
http://dx.doi.org/10.3390/jcm12093244

Ejemplares similares